Skip to main content
Smart Investors Daily
Stryker Corporation logo

NYSE · SYK

Stryker Corporation

Healthcare · Medical - Devices

$318.15

Down-$5.07 (-1.59%)

Updated Nov 20, 2026, 1:25 AM

SID Score

5.6/10

Composite research score

Smart Money

35/100

Bearish

Market cap
134.97B
P/E ratio
45.86
Dividend yield
1.06%
52-week range
$267.00 – $389.33
Volume
3.28M
Avg. volume
1.61M

Price performance · SYK

SYK price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 18, 2026

SYK closed at $318.15 after 20 trading sessions, up 3.60% for the selected period.

Last close
$318.15
Period change
+3.60%
Period low
$291.86
Period high
$339.65
Daily close
View OHLC price history
SYK OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 18, 2026$313.88$321.83$313.36$318.153.28M
Nov 17, 2026$309.12$319.33$308.00$317.544.57M
Nov 16, 2026$314.34$315.50$309.2401$310.722.48M
Nov 13, 2026$316.07$316.07$306.545$309.643.25M
Nov 12, 2026$321.42$323.61$311.8101$312.392.44M
Nov 11, 2026$319.23$320.70$315.37$318.793.22M
Nov 10, 2026$324.07$324.76$317.87$324.292.64M
Nov 9, 2026$328.88$330.33$324.66$325.732.55M
Nov 6, 2026$324.41$328.015$322.56$325.873.78M
Nov 5, 2026$342.45$349.48$329.855$335.084.46M
Nov 4, 2026$327.94$342.65$322.00$339.656.49M
Nov 3, 2026$307.12$312.74$306.41$310.552.59M
Nov 2, 2026$294.31$307.895$293.00$306.813.74M
Oct 30, 2026$287.97$299.17$282.18$291.866.44M
Oct 29, 2026$306.99$312.795$305.87$311.753.08M
Oct 28, 2026$297.52$305.29$297.00$304.002.33M
Oct 27, 2026$304.06$305.62$298.86$301.422.27M
Oct 26, 2026$305.43$307.47$301.78$306.131.89M
Oct 23, 2026$305.01$309.57$305.00$307.151.98M
Oct 22, 2026$299.80$309.68$299.36$307.082.8M

Latest SYK news

The latest Smart Investors Daily articles mentioning SYK.

SYK research

Overview

Company profile and research snapshot.

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$419.33
Implied upside
—
Analysts
20
SYK recent ratings
DateFirmRatingTarget
Nov 18, 2026BTIGBuy—
Nov 9, 2026Piper SandlerOverweight—
Nov 2, 2026StifelBuy—
Nov 2, 2026Truist SecuritiesHold—
Oct 30, 2026CitigroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

A $19 Billion Fund Bought These 3 Stocks

Key TakeawaysVeritas Asset Management, a firm that manages $19. 1 billion, added to Intercontinental Exchange, Vulcan Materials and Stryker in the third quarter, its new 13F shows.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.